Key Highlights
- Michael Fraser, PhD, joins CAP with 25+ years of experience in medical association management.
- Committed to innovation in digital pathology, AI, precision medicine, and health equity.
- Aims to strengthen CAP’s global influence in accreditation and proficiency testing.
Source: Business Wire
Notable Quotes
- “I bring a ‘startup energy’ that lets me see things from a fresh perspective—the opportunities as well as the challenges. That’s what fuels my passion, and I can’t wait to learn more about the specialty and contribute to the CAP’s ongoing success.” – Michael Fraser, Incoming CEO at CAP
- “During our national search for a new CEO, I had multiple great conversations with Mike Fraser, imagining the possibilities for our specialty and our organization. Mike and I are both excited about him partnering with us on strategy, supporting innovation in pathology and the CAP, and helping us grow, while keeping our core, foundational objectives front and center.” – Donald Karcher, MD, FCAP, President at CAP
SoHC's Take
Michael Fraser’s appointment as CEO of the College of American Pathologists (CAP) marks a significant moment for the organization, emphasizing a continued commitment to excellence in the field of pathology. Fraser’s extensive experience and fresh perspective promise to steer CAP towards innovative solutions in the face of healthcare’s evolving challenges, particularly in areas like digital pathology and health equity. His leadership style, characterized by transparency and empowerment, positions him well to foster strong relationships within the CAP and further its mission on a global scale. This transition underscores the CAP’s role as a leader in advocating for quality and excellence in pathology, ensuring that it remains at the forefront of advancements in laboratory medicine.
